Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting report.

Conference paper

Pollard AJ. et al, (2020), Biologicals : journal of the International Association of Biological Standardization

Towards new TB vaccines.

Journal article

Brazier B. and McShane H., (2020), Seminars in immunopathology

Controlled Human Infection Models - Is it Really Feasible to Give People Tuberculosis?

Journal article

McShane H., (2020), Am J Respir Crit Care Med

Identification of antigens presented by MHC for vaccines against tuberculosis.

Journal article

Bettencourt P. et al, (2020), NPJ Vaccines, 5

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges.

Journal article

Stylianou E. et al, (2019), Expert review of vaccines, 18, 1271 - 1284

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.

Journal article

Müller J. et al, (2019), JCI insight, 4

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis

Conference paper

Bettencourt P. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1691 - 1691

Insights and challenges in tuberculosis vaccine development.

Journal article

McShane H., (2019), Lancet Respir Med

A CLINICAL CHALLENGE TRIAL DELIVERING AEROSOL BCG AS A CONTROLLED HUMAN INFECTION IN HEALTHY BCG-NAIVE, UK ADULTS: ESTABLISHING OPTIMAL DOSE AND EVALUATING SAFETY

Conference paper

Marshall JL. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 368 - 369

The Humoral Immune Response to BCG Vaccination.

Journal article

Tanner R. et al, (2019), Frontiers in Immunology, 10

Load More